Skopos Labs, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,064 shares of HRMY stock, worth $35,952. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,064
Previous 94
1031.91%
Holding current value
$35,952
Previous $3,000
1066.67%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.9MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$224 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$197 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$159 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$53.4 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$43.5 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...